LV10119B - Method of preparing lysocyme dimers - Google Patents

Method of preparing lysocyme dimers Download PDF

Info

Publication number
LV10119B
LV10119B LVP-92-506A LV920506A LV10119B LV 10119 B LV10119 B LV 10119B LV 920506 A LV920506 A LV 920506A LV 10119 B LV10119 B LV 10119B
Authority
LV
Latvia
Prior art keywords
lysozyme
solution
elution
elution step
fractions
Prior art date
Application number
LVP-92-506A
Other languages
English (en)
Latvian (lv)
Other versions
LV10119A (lv
Inventor
Peter Herrmann
Peter Klein
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of LV10119A publication Critical patent/LV10119A/xx
Publication of LV10119B publication Critical patent/LV10119B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
LVP-92-506A 1990-01-08 1992-12-28 Method of preparing lysocyme dimers LV10119B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/US1990/000140 WO1991010731A1 (en) 1990-01-08 1990-01-08 Method of preparing lysozyme dimers
CA002073351A CA2073351C (en) 1990-01-08 1990-01-08 Lysozyme dimers and method of preparing them
HU9202250A HU214509B (hu) 1990-01-08 1990-01-08 Eljárás tisztított lizozim dimerek előállítására
SG1996007945A SG49871A1 (en) 1990-01-08 1990-01-08 Method of preparing lysozyme dimers
RO92-0931A RO114805B1 (ro) 1990-01-08 1990-01-08 Dimer de lizozim purificat si procedeu de obtinere a acestuia
OA60242A OA09706A (en) 1990-01-08 1992-07-07 Method of preparing lysozyme dimers.

Publications (2)

Publication Number Publication Date
LV10119A LV10119A (lv) 1994-05-10
LV10119B true LV10119B (en) 1995-02-20

Family

ID=33136306

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-506A LV10119B (en) 1990-01-08 1992-12-28 Method of preparing lysocyme dimers

Country Status (21)

Country Link
EP (1) EP0509984B1 (ro)
JP (1) JP2732514B2 (ro)
KR (1) KR0158216B1 (ro)
AU (1) AU654651B2 (ro)
BG (1) BG61040B1 (ro)
BR (1) BR9007971A (ro)
CA (1) CA2073351C (ro)
DE (1) DE69032375T2 (ro)
DK (1) DK0509984T3 (ro)
ES (1) ES2118719T3 (ro)
FI (1) FI101399B1 (ro)
HK (1) HK1007456A1 (ro)
HU (1) HU214509B (ro)
LT (1) LT3422B (ro)
LV (1) LV10119B (ro)
MC (2) MC2242A1 (ro)
NO (1) NO302484B1 (ro)
OA (1) OA09706A (ro)
RO (1) RO114805B1 (ro)
SG (1) SG49871A1 (ro)
WO (1) WO1991010731A1 (ro)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
CN108424464A (zh) * 2011-10-05 2018-08-21 洛克菲勒大学 二聚噬菌体溶素
CN111751468A (zh) * 2020-07-03 2020-10-09 上海艾魁英生物科技有限公司 溶菌酶二聚体的纯化及其标准品制备的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850731B2 (en) 2006-10-04 2010-12-14 Seaspine, Inc. Articulating spinal implant

Also Published As

Publication number Publication date
AU654651B2 (en) 1994-11-17
LTIP594A (en) 1994-12-27
HK1007456A1 (en) 1999-04-09
BG61040B1 (bg) 1996-09-30
KR0158216B1 (ko) 1998-11-16
CA2073351A1 (en) 1991-07-09
NO922626D0 (no) 1992-07-03
JP2732514B2 (ja) 1998-03-30
JPH05505092A (ja) 1993-08-05
BR9007971A (pt) 1992-11-17
WO1991010731A1 (en) 1991-07-25
FI923123A0 (fi) 1992-07-07
EP0509984B1 (en) 1998-06-03
MC2243A1 (fr) 1993-02-23
ES2118719T3 (es) 1998-10-01
HUT65931A (en) 1994-07-28
CA2073351C (en) 2001-10-16
OA09706A (en) 1993-08-30
DE69032375D1 (de) 1998-07-09
NO922626L (no) 1992-09-07
LT3422B (en) 1995-09-25
MC2242A1 (fr) 1993-02-23
EP0509984A1 (en) 1992-10-28
LV10119A (lv) 1994-05-10
FI101399B (fi) 1998-06-15
AU4847490A (en) 1991-08-05
RO114805B1 (ro) 1999-07-30
NO302484B1 (no) 1998-03-09
DE69032375T2 (de) 1998-11-19
SG49871A1 (en) 1998-06-15
BG96578A (bg) 1993-12-24
HU214509B (hu) 1998-03-30
FI101399B1 (fi) 1998-06-15
FI923123A (fi) 1992-07-07
HU9202250D0 (en) 1992-10-28
DK0509984T3 (da) 1999-03-22

Similar Documents

Publication Publication Date Title
GB2058081A (en) Method of producing a substance for curing human granulocytopoenia
LV10119B (en) Method of preparing lysocyme dimers
US5314816A (en) Method of preparing lysozyme dimers
EP0292663B1 (en) A method for producing vitronectin
US5989880A (en) Method of preparing lysozyme dimers
US4681844A (en) Process for producing an Interleukin-1 preparation
RU2067617C1 (ru) Способ получения димера лизоцима
US4661447A (en) Regulatory glycoprotein for immune response and the use there of in the production of T-cell growth factor
JPS6028935A (ja) 新規ヒト抗体産生増強因子およびその製造法
US4808533A (en) Method of preventing T-cell blastogenesis
JP2551424B2 (ja) ＴＧＦ−β制御糖タンパク質サブユニツト
CA2073350C (en) Ribonuclease dimers and method of preparing them
JPH0725798B2 (ja) ＴＧＦ−β制御糖タンパク質
SU767121A1 (ru) Способ выделени и очистки трипсина и химотрипсина
MIYAKOSHI et al. Mitogenic substances in staphage lysate
JPH0427397A (ja) 細胞分化誘導物質
Bowers Stimulation of lymphocytes with periodate or neuraminidase plus galactose oxidase
Bodo 19. Konferenz der Gesellschaft für Biologische Chemie Purification and Chemical Characterization of Interferon
JPS6237605B2 (ro)
Jubinsky Hemopoietic growth factor purification and action.
JPH0566398B2 (ro)
JPS60246319A (ja) マクロフア−ジ活性化物質
JPH01272600A (ja) 分化誘導因子